Extracranial metastasis of glioblastoma with genomic analysis: a case report and review of the literature.

BACKGROUND

Glioblastoma (GBM) is the first most frequent type of primary malignant brain tumors in adults. It is basically confined to the brain, and extracranial metastases (ECM) are rare. The genomic features of GBM with ECM are not fully elucidated.

CASE DESCRIPTION: Here, we present a case of a male patient with headache and left eye vision loss for 2 months who had a left occipital lobe tumor. GBM of grade IV [isocitrate dehydrogenase 1 (IDH-1) wild type] was diagnosed based on the histological profiles of intracranial tumor according to the World Health Organization standard. ECM of GBM located in the mediastinal lymph node occurred 6 months after resection of the intracranial tumor. High throughput gene sequencing was performed using ECM lesions. Mutated genes included tumor protein 53 (TP53), CUB and Sushi multiple domains 3 (CSMD3), poly(ADP-ribose) polymerase family member 4 (PARP4), and PTEN. The patient underwent surgery, radiotherapy, chemotherapy, and anti-angiogenic drug treatment. Unfortunately, the patient died 8 months after surgery.

CONCLUSIONS

ECM of GBM is rare, and its prognosis is very poor. Mutated genes in ECM included TP53, CSMD3, PARP4, and PTEN in our case. Genomic analysis provides important insights into GBM and its ECM.